1st Circ. Asked To Uphold Class Cert. In Prograf MDL
A class of consumers and companies in multidistrict antitrust litigation accusing Astellas Pharma US LLC of delaying entry of a generic form of its immunosuppressant Prograf told the First Circuit to...To view the full article, register now.
Already a subscriber? Click here to view full article